WAM
ABBV icon

Werlinich Asset Management’s AbbVie ABBV Stock Holding History

Werlinich Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.66M Buy
18,535
+50
+0.3% +$10.8K 1.78% 13
2026
Q1 		$4.02M Buy
18,485
+625
+3% +$139K 1.95% 14
2025
Q4 		$4.1M Buy
17,860
+100
+0.6% +$22.8K 2.02% 14
2025
Q3 		$4.11M Hold
17,760
– – 2.04% 14
2025
Q2 		$3.3M Hold
17,760
– – 1.8% 17
2025
Q1 		$3.72M Hold
17,760
– – 2.36% 12
2024
Q4 		$3.13M Buy
17,760
+110
+0.6% +$20.2K 1.82% 16
2024
Q3 		$3.49M Hold
17,650
– – 2.02% 13
2024
Q2 		$2.98M Buy
17,650
+25
+0.1% +$4.14K 1.86% 15
2024
Q1 		$3.18M Sell
17,625
-25
-0.1% -$4.31K 2.08% 13
2023
Q4 		$2.73M Sell
17,650
-417
-2% -$60.8K 2.07% 15
2023
Q3 		$2.69M Buy
18,067
+507
+3% +$74.4K 2.22% 14
2023
Q2 		$2.37M Hold
17,560
– – 1.9% 19
2023
Q1 		$2.8M Buy
17,560
+50
+0.3% +$7.64K 2.46% 12
2022
Q4 		$2.83M Hold
17,510
– – 2.62% 14
2022
Q3 		$2.35M Sell
17,510
-150
-0.8% -$21.5K 2.4% 14
2022
Q2 		$2.7M Hold
17,660
– – 2.53% 12
2022
Q1 		$2.86M Sell
17,660
-400
-2% -$58.1K 2.18% 14
2021
Q4 		$2.45M Hold
18,060
– – 1.78% 18
2021
Q3 		$1.95M Buy
18,060
+100
+0.6% +$11.4K 1.58% 24
2021
Q2 		$2.02M Hold
17,960
– – 1.63% 21
2021
Q1 		$1.94M Buy
+17,960
New +$1.92M 1.71% 22

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Werlinich Asset Management's ABBV Position: Q2 2026 in Review

Werlinich Asset Management increased its AbbVie (ABBV) stake by 0.27% in Q2 2026, buying an estimated $10.8K and bringing the position to 18,535 shares worth $4.66M. The position accounts for 1.78% of the portfolio, ranked #13.

Werlinich Asset Management first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. 1,042 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Werlinich Asset Management held 18,535 shares of AbbVie worth $4.66M as of Q2 2026.
  • Werlinich Asset Management bought 50 AbbVie shares in Q2 2026, an estimated $10.8K.
  • AbbVie made up 1.78% of Werlinich Asset Management's portfolio in Q2 2026, its #13 holding.
  • Werlinich Asset Management first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
  • 1,042 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Werlinich Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.